417 related articles for article (PubMed ID: 35804863)
1. Recent Advances and Challenges in Uveal Melanoma Immunotherapy.
Fu Y; Xiao W; Mao Y
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804863
[TBL] [Abstract][Full Text] [Related]
2. Uveal melanoma: Recent advances in immunotherapy.
Sorrentino FS; De Rosa F; Di Terlizzi P; Toneatto G; Gabai A; Finocchio L; Salati C; Spadea L; Zeppieri M
World J Clin Oncol; 2024 Jan; 15(1):23-31. PubMed ID: 38292657
[TBL] [Abstract][Full Text] [Related]
3. New immunotherapy approaches as the most effective treatment for uveal melanoma.
Eteghadi A; Ebrahimi M; Keshel SH
Crit Rev Oncol Hematol; 2024 Feb; 194():104260. PubMed ID: 38199429
[TBL] [Abstract][Full Text] [Related]
4. New Treatment Horizons in Uveal and Cutaneous Melanoma.
Brănişteanu DE; Porumb-Andrese E; Porumb V; Stărică A; Moraru AD; Nicolescu AC; Zemba M; Brănişteanu CI; Brănişteanu G; Brănişteanu DC
Life (Basel); 2023 Jul; 13(8):. PubMed ID: 37629523
[TBL] [Abstract][Full Text] [Related]
5. Development of new therapeutic options for the treatment of uveal melanoma.
Wang JZ; Lin V; Toumi E; Wang K; Zhu H; Conway RM; Madigan MC; Murray M; Cherepanoff S; Zhou F; Shu W
FEBS J; 2021 Nov; 288(21):6226-6249. PubMed ID: 33838075
[TBL] [Abstract][Full Text] [Related]
6. Molecular Insights and Emerging Strategies for Treatment of Metastatic Uveal Melanoma.
Mallone F; Sacchetti M; Lambiase A; Moramarco A
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992823
[TBL] [Abstract][Full Text] [Related]
7. The Role of Immune Checkpoint Blockade in Uveal Melanoma.
Wessely A; Steeb T; Erdmann M; Heinzerling L; Vera J; Schlaak M; Berking C; Heppt MV
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013269
[TBL] [Abstract][Full Text] [Related]
8. Uveal Melanoma Metastasis.
Rossi E; Croce M; Reggiani F; Schinzari G; Ambrosio M; Gangemi R; Tortora G; Pfeffer U; Amaro A
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830841
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case report.
Reiter S; Schroeder C; Broche J; Sinnberg T; Bonzheim I; Süsskind D; Flatz L; Forschner A
Front Oncol; 2023; 13():1167791. PubMed ID: 37207136
[TBL] [Abstract][Full Text] [Related]
10. Immuno-oncology approaches in uveal melanoma: tebentafusp and beyond.
Gerard C; Shum B; Nathan P; Turajlic S
Immunooncol Technol; 2023 Sep; 19():100386. PubMed ID: 37483658
[TBL] [Abstract][Full Text] [Related]
11. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
[TBL] [Abstract][Full Text] [Related]
12. Solitary Metastases Presentation from Uveal Melanoma: Report of 3 Cases and a Comprehensive Review of the Literature.
Pereira PM; Luís A; Passos MJ; Gouveia E
Ocul Oncol Pathol; 2023 Feb; 8(4-6):203-210. PubMed ID: 36925729
[TBL] [Abstract][Full Text] [Related]
13. Uveal Melanoma: Identifying Immunological and Chemotherapeutic Targets to Treat Metastases.
Jager MJ; Dogrusöz M; Woodman SE
Asia Pac J Ophthalmol (Phila); 2017; 6(2):179-185. PubMed ID: 28399339
[TBL] [Abstract][Full Text] [Related]
14. Uveal melanoma: progress in molecular biology and therapeutics.
Li Y; Shi J; Yang J; Ge S; Zhang J; Jia R; Fan X
Ther Adv Med Oncol; 2020; 12():1758835920965852. PubMed ID: 33149769
[TBL] [Abstract][Full Text] [Related]
15. Role of immune checkpoint inhibitors and novel immunotherapies in uveal melanoma.
Jindal V
Chin Clin Oncol; 2018 Feb; 7(1):8. PubMed ID: 29486567
[TBL] [Abstract][Full Text] [Related]
16. Liver metastasis in uveal melanoma - treatment options and clinical outcome.
Kaštelan S; Mrazovac Zimak D; Ivanković M; Marković I; Gverović Antunica A
Front Biosci (Landmark Ed); 2022 Feb; 27(2):72. PubMed ID: 35227015
[TBL] [Abstract][Full Text] [Related]
17. Uveal melanoma.
Jager MJ; Shields CL; Cebulla CM; Abdel-Rahman MH; Grossniklaus HE; Stern MH; Carvajal RD; Belfort RN; Jia R; Shields JA; Damato BE
Nat Rev Dis Primers; 2020 Apr; 6(1):24. PubMed ID: 32273508
[TBL] [Abstract][Full Text] [Related]
18. Tebentafusp as a Promising Drug for the Treatment of Uveal Melanoma.
Al Balushi K; Al Hadhrami A; Balushi HA; Al Lawati A; Das S
Curr Drug Targets; 2024; 25(3):149-157. PubMed ID: 38115619
[TBL] [Abstract][Full Text] [Related]
19. How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma.
Marseglia M; Amaro A; Solari N; Gangemi R; Croce E; Tanda ET; Spagnolo F; Filaci G; Pfeffer U; Croce M
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922591
[TBL] [Abstract][Full Text] [Related]
20. Evolving Management of Stage IV Melanoma.
Switzer B; Piperno-Neumann S; Lyon J; Buchbinder E; Puzanov I
Am Soc Clin Oncol Educ Book; 2023 Jan; 43():e397478. PubMed ID: 37141553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]